US Stock MarketDetailed Quotes

CDBT CHINA DASHENG BIOTECHNOLOGY COMPANY

Watchlist
  • 0.027
  • -0.023-46.60%
15min DelayClose Dec 20 16:00 ET
1.09MMarket Cap-1.34P/E (TTM)

CHINA DASHENG BIOTECHNOLOGY COMPANY Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(Q3)Mar 30, 2009
(Q2)Dec 31, 2008
(Q1)Sep 30, 2008
(FY)Jun 30, 2008
(Q4)Jun 30, 2008
(Q3)Mar 30, 2008
(FY)Oct 30, 2007
(Q4)Oct 30, 2007
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-233.55K
0
476.45%2.98M
341,855.43%4.4M
6,341.14%381.08K
25,316.49%4.1M
21,293.21%2.06M
58,639.89%516.91K
-367.24%-16.25K
-9.74K
Net income from continuing operations
---966.71K
--0
194.80%1.3M
17,691.72%1.73M
16,956.24%1.33M
6,876.54%4.64M
4,552.06%2.04M
9,190.02%442.59K
-305.88%-68.45K
---45.86K
Operating gains losses
--349.43K
----
--293.61K
--375.25K
--309.64K
--553.48K
----
----
----
----
Depreciation and amortization
----
----
91.37%202.27K
33,874.32%137.6K
16,474.32%67.13K
38,564.51%626.37K
68,821.23%279.13K
25,996.79%105.69K
0.00%1.62K
--405
Other non cash items
--339.83K
----
---104
---5.29K
--11.81K
--62.87K
----
----
----
----
Change In working capital
--43.91K
--0
227.46%1.18M
26,436.16%2.16M
-97,672.46%-1.34M
-3,625.61%-1.78M
-2,545.56%-873.38K
6,638.40%360.1K
137.17%50.58K
--35.71K
-Change in receivables
----
----
-261.49%-351.92K
--1.8M
---1.87M
---125.02K
--387.53K
--217.92K
----
----
-Change in inventory
----
----
93.42%-12.01K
---27.82K
---43.79K
1,196.08%271.55K
--74.61K
---182.59K
1,454.30%20.95K
----
-Change in prepaid assets
--40.76K
--0
29.91%300.67K
--243.69K
---344.54K
--320.23K
---799.64K
--231.44K
----
----
-Change in payables and accrued expense
--3.15K
--0
900.34%1.11M
---566.86K
--298.6K
---227.35K
--83.26K
---138.38K
----
----
-Change in other current assets
----
----
--72.75K
----
----
---1.29M
----
----
----
----
-Change in other current liabilities
----
----
----
---58.88K
---3.31K
-2,579.97%-734.67K
--1.28M
---375.39K
48.29%29.62K
----
-Change in other working capital
----
----
----
----
45,670.27%626.6K
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
---233.55K
--0
476.45%2.98M
341,855.43%4.4M
6,341.14%381.08K
25,316.49%4.1M
21,293.21%2.06M
58,639.89%516.91K
-367.24%-16.25K
---9.74K
Investing cash flow
Cash flow from continuing investing activities
6.22K
0
-7,422.15%-449.37K
1.94K
0
-47,789.64%-3.92M
-53,269.57%-3.89M
-5.97K
8.21K
7.31K
Net PPE purchase and sale
----
----
-24,855.27%-1.49M
----
----
---30.68K
---2.28K
---5.97K
----
----
Net business purchase and sale
--6.22K
--0
----
----
----
----
----
----
----
----
Net investment purchase and sale
----
----
----
----
----
---5.1M
----
----
----
----
Net other investing changes
----
----
----
----
----
14,706.01%1.22M
----
----
--8.21K
--7.31K
Cash from discontinued investing activities
Investing cash flow
--6.22K
--0
-7,422.15%-449.37K
--1.94K
--0
-47,789.64%-3.92M
-53,269.57%-3.89M
---5.97K
--8.21K
--7.31K
Financing cash flow
Cash flow from continuing financing activities
334.34K
0
-103.56%-2.44K
1.19M
321.09K
-103,101.78%-927.02K
-74,285.67%-667.67K
68.45K
900
900
Net issuance payments of debt
--96.56K
--0
----
----
--321.09K
---1.1M
--94.43K
---46.41K
----
----
Net common stock issuance
----
----
----
----
----
----
----
----
--900
----
Net other financing activities
--237.77K
----
----
----
----
--176.51K
---762.1K
--114.86K
----
----
Cash from discontinued financing activities
Financing cash flow
--334.34K
--0
-103.56%-2.44K
--1.19M
--321.09K
-103,101.78%-927.02K
-74,285.67%-667.67K
--68.45K
--900
--900
Net cash flow
Beginning cash position
--0
--0
199.83%7.82M
123,242.05%2.38M
21,777.58%1.56M
18,347.09%1.32M
219,235.98%3.34M
405,574.81%2.61M
575.85%7.14K
--1.52K
Current changes in cash
--107K
----
336.31%2.53M
434,560.64%5.6M
13,587.74%702.17K
-10,356.93%-746.31K
-163,584.18%-2.49M
65,739.66%579.39K
-217.37%-7.14K
---1.52K
Effect of exchange rate changes
---99.71K
----
-57.82%64.38K
---156.61K
--118.16K
--991.15K
--713.83K
--152.61K
----
----
End cash Position
--7.29K
--0
211.73%10.41M
1,216,226.44%7.82M
123,242.05%2.38M
--1.56M
--1.56M
219,235.98%3.34M
--0
--0
Free cash flow
---233.55K
--0
191.78%1.49M
341,855.43%4.4M
6,341.14%381.08K
25,127.68%4.07M
21,269.82%2.06M
57,961.02%510.94K
-367.24%-16.25K
---9.74K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Jun 30, 2023(FY)Jun 30, 2022(Q3)Mar 30, 2009(Q2)Dec 31, 2008(Q1)Sep 30, 2008(FY)Jun 30, 2008(Q4)Jun 30, 2008(Q3)Mar 30, 2008(FY)Oct 30, 2007(Q4)Oct 30, 2007
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -233.55K0476.45%2.98M341,855.43%4.4M6,341.14%381.08K25,316.49%4.1M21,293.21%2.06M58,639.89%516.91K-367.24%-16.25K-9.74K
Net income from continuing operations ---966.71K--0194.80%1.3M17,691.72%1.73M16,956.24%1.33M6,876.54%4.64M4,552.06%2.04M9,190.02%442.59K-305.88%-68.45K---45.86K
Operating gains losses --349.43K------293.61K--375.25K--309.64K--553.48K----------------
Depreciation and amortization --------91.37%202.27K33,874.32%137.6K16,474.32%67.13K38,564.51%626.37K68,821.23%279.13K25,996.79%105.69K0.00%1.62K--405
Other non cash items --339.83K-------104---5.29K--11.81K--62.87K----------------
Change In working capital --43.91K--0227.46%1.18M26,436.16%2.16M-97,672.46%-1.34M-3,625.61%-1.78M-2,545.56%-873.38K6,638.40%360.1K137.17%50.58K--35.71K
-Change in receivables ---------261.49%-351.92K--1.8M---1.87M---125.02K--387.53K--217.92K--------
-Change in inventory --------93.42%-12.01K---27.82K---43.79K1,196.08%271.55K--74.61K---182.59K1,454.30%20.95K----
-Change in prepaid assets --40.76K--029.91%300.67K--243.69K---344.54K--320.23K---799.64K--231.44K--------
-Change in payables and accrued expense --3.15K--0900.34%1.11M---566.86K--298.6K---227.35K--83.26K---138.38K--------
-Change in other current assets ----------72.75K-----------1.29M----------------
-Change in other current liabilities ---------------58.88K---3.31K-2,579.97%-734.67K--1.28M---375.39K48.29%29.62K----
-Change in other working capital ----------------45,670.27%626.6K--------------------
Cash from discontinued investing activities
Operating cash flow ---233.55K--0476.45%2.98M341,855.43%4.4M6,341.14%381.08K25,316.49%4.1M21,293.21%2.06M58,639.89%516.91K-367.24%-16.25K---9.74K
Investing cash flow
Cash flow from continuing investing activities 6.22K0-7,422.15%-449.37K1.94K0-47,789.64%-3.92M-53,269.57%-3.89M-5.97K8.21K7.31K
Net PPE purchase and sale ---------24,855.27%-1.49M-----------30.68K---2.28K---5.97K--------
Net business purchase and sale --6.22K--0--------------------------------
Net investment purchase and sale -----------------------5.1M----------------
Net other investing changes --------------------14,706.01%1.22M----------8.21K--7.31K
Cash from discontinued investing activities
Investing cash flow --6.22K--0-7,422.15%-449.37K--1.94K--0-47,789.64%-3.92M-53,269.57%-3.89M---5.97K--8.21K--7.31K
Financing cash flow
Cash flow from continuing financing activities 334.34K0-103.56%-2.44K1.19M321.09K-103,101.78%-927.02K-74,285.67%-667.67K68.45K900900
Net issuance payments of debt --96.56K--0----------321.09K---1.1M--94.43K---46.41K--------
Net common stock issuance ----------------------------------900----
Net other financing activities --237.77K------------------176.51K---762.1K--114.86K--------
Cash from discontinued financing activities
Financing cash flow --334.34K--0-103.56%-2.44K--1.19M--321.09K-103,101.78%-927.02K-74,285.67%-667.67K--68.45K--900--900
Net cash flow
Beginning cash position --0--0199.83%7.82M123,242.05%2.38M21,777.58%1.56M18,347.09%1.32M219,235.98%3.34M405,574.81%2.61M575.85%7.14K--1.52K
Current changes in cash --107K----336.31%2.53M434,560.64%5.6M13,587.74%702.17K-10,356.93%-746.31K-163,584.18%-2.49M65,739.66%579.39K-217.37%-7.14K---1.52K
Effect of exchange rate changes ---99.71K-----57.82%64.38K---156.61K--118.16K--991.15K--713.83K--152.61K--------
End cash Position --7.29K--0211.73%10.41M1,216,226.44%7.82M123,242.05%2.38M--1.56M--1.56M219,235.98%3.34M--0--0
Free cash flow ---233.55K--0191.78%1.49M341,855.43%4.4M6,341.14%381.08K25,127.68%4.07M21,269.82%2.06M57,961.02%510.94K-367.24%-16.25K---9.74K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.